Functional characterization of T lymphocytes propagated from human lung carcinomas.

[1]  S. Rosenberg,et al.  The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo. , 1985, Journal of immunology.

[2]  T. Fuller,et al.  Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection. , 1985, Journal of immunology.

[3]  S. Krane,et al.  Interleukin 1 production by the human monocyte cell line U937 requires a lymphokine induction signal distinct from interleukin 2 or interferons. , 1985, Journal of Immunology.

[4]  E. Reinherz,et al.  Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3- populations. , 1985, Journal of immunology.

[5]  B. Ransil,et al.  Accessory cell requirement for activation antigen expression and cell cycle progression by human T lymphocytes. , 1984, Journal of immunology.

[6]  M. Bevan,et al.  Release of discrete interferons by cytotoxic T lymphocytes in response to immune and nonimmune stimuli. , 1984, Journal of immunology.

[7]  A. Kelso,et al.  Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures. , 1984, Journal of immunology.

[8]  G. Callahan.  Soluble factors produced during an immune response regulate Ia antigen expression by murine adenocarcinoma and fibrosarcoma cells. , 1984, Journal of immunology.

[9]  L. Lanier,et al.  Human lymphocyte subpopulations identified by using three-color immunofluorescence and flow cytometry analysis: correlation of Leu-2, Leu-3, Leu-7, Leu-8, and Leu-11 cell surface antigen expression. , 1984, Journal of immunology.

[10]  S. Krane,et al.  Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes. , 1983, Journal of immunology.

[11]  P. P. Jones,et al.  Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon. , 1983, Journal of immunology.

[12]  R. Moscicki,et al.  T-cell subsets in human lymphocytes maintained in IL-2 medium after PHA or mixed lymphocyte reaction activation. , 1983, Clinical immunology and immunopathology.

[13]  N. Cerf-Bensussan,et al.  Immunohistologic and immunoelectron microscopic characterization of the mucosal lymphocytes of human small intestine by the use of monoclonal antibodies. , 1983, Journal of immunology.

[14]  J. Strominger,et al.  Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content , 1983, The Journal of experimental medicine.

[15]  H. Eisen,et al.  Inhibition of cytotoxic T lymphocyte activity by concanavalin A. , 1982, Journal of immunology.

[16]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.

[17]  E. Klein,et al.  Specificity of auto‐tumor cytotoxicity exerted by fresh, activated and propagated human t lymphocytes , 1982, International journal of cancer.

[18]  G. Bonnard,et al.  Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2 , 1982, International journal of cancer.

[19]  J. Ortaldo,et al.  Natural killer cells: their roles in defenses against disease. , 1981, Science.

[20]  T. Waldmann,et al.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. , 1981, Journal of immunology.

[21]  L. Nadler,et al.  Characterization of a human B lymphocyte-specific antigen. , 1980, Journal of immunology.

[22]  Kendall A. Smith,et al.  T‐Cell Growth Factor , 1980, Immunological reviews.

[23]  M. Favata,et al.  The functional relationship of the interleukins , 1980, The Journal of experimental medicine.

[24]  Ellis L. Reinherz,et al.  The differentiation and function of human T lymphocytes , 1980, Cell.

[25]  E. Reinherz,et al.  A monoclonal antibody reactive with human peripheral blood monocytes. , 1980, Journal of immunology.

[26]  R. North,et al.  T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor , 1980, The Journal of experimental medicine.

[27]  E. Reinherz,et al.  Further characterization of the human inducer T cell subset defined by monoclonal antibody. , 1979, Journal of immunology.

[28]  M. Moore,et al.  Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours , 1979, International journal of cancer.

[29]  H. Wigzell,et al.  Long term growth in vitro of human T cell blasts with maintenance of specificity and function. , 1979, Journal of immunology.

[30]  B. Benacerraf,et al.  Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo. , 1978, Journal of immunology.

[31]  Kendall A. Smith,et al.  T cell growth factor: parameters of production and a quantitative microassay for activity. , 1978, Journal of immunology.